Skip to main content
TipRanks
Go Ultimate75% OFF

Actinium Pharmaceuticals (7AY1) Q3 2025 Earnings Report

2 Followers

DE:7AY1 Q3 2025 EPS Results

Actual EPS
-EUR 0.15
Consensus EPS
-EUR 0.16
Beat/Miss
Beat by +EUR 0.02
One Year Ago EPS
-EUR 0.34

DE:7AY1 Q3 2025 Revenue Results

Actual Revenue
EUR 81.86K
Expected Revenue
EUR 61.85K
Beat/Miss
Beat by +EUR 20.01K
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q3 2025
Date
11/24/2025
Time
TBA
Conference Call
Monday, November 24, 2025
DE:7AY1 Upcoming Earnings

Actinium Pharmaceuticals's next earnings date is estimated for November 23, 2026, based on past reporting schedules.

Q3 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:7AY1 Earnings History

DE:7AY1 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 23, 20262026 (Q3)-0.19-0.17-0.15-16.25% (-0.02)―
Mar 13, 20262025 (Q4)-0.17-0.17-0.199.52% (+0.02)
Nov 24, 20252025 (Q3)-0.16-0.15-0.3456.76% (+0.19)
Mar 14, 20252024 (Q4)-0.34-0.19-0.3138.24% (+0.12)
Nov 18, 20242024 (Q3)-0.35-0.34-0.4524.49% (+0.11)
Mar 15, 20242023 (Q4)-0.52-0.31-0.3819.05% (+0.07)
May 12, 20232023 (Q1)―--0.21―
Apr 03, 20232022 (Q4)-0.38-0.39-0.21-86.96% (-0.18)
Aug 09, 20192019 (Q2)―-0.82-1.0925.00% (+0.27)
May 10, 20192019 (Q1)―-1.36-1.9128.57% (+0.55)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed